Prognostic significance of mast cell count following curative resection for pancreatic ductal adenocarcinoma

Surgery

Volumn 149, Issue 4, 2011, Pages 576-584

  Cai, Shou Wang ^a   Yang, Shi Zhong ^a   Gao, Jie ^a   Pan, Ke ^a   Chen, Ji Ye ^a   Wang, Yu Lan ^a   Wei, Li Xin ^a   Dong, Jia Hong ^a  

^a CHINESE PLA GENERAL HOSPITAL   (China)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; AGED; ARTICLE; CANCER STAGING; FEMALE; HUMAN; HUMAN CELL; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; LYMPH NODE METASTASIS; MAJOR CLINICAL STUDY; MALE; MAST CELL; MICROVASCULATURE; OVERALL SURVIVAL; PANCREAS ADENOCARCINOMA; PANCREAS RESECTION; PRIORITY JOURNAL; PROGNOSIS; TUMOR GROWTH;

ADULT; AGED; CARCINOMA, PANCREATIC DUCTAL; CELL COUNT; HUMANS; IMMUNOHISTOCHEMISTRY; MALE; MAST CELLS; MICROVESSELS; MIDDLE AGED; OBSERVER VARIATION; PANCREAS; PANCREATIC NEOPLASMS; PROGNOSIS; PROPORTIONAL HAZARDS MODELS;

EID: 79952709160     PISSN: 00396060     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.surg.2010.10.009     Document Type: Article

References (38)

1. Bogoevski D, Strate T, Yekebas EF, Izbicki JR. Pancreatic cancer: a generalized disease-prognostic impact of cancer cell dissemination. Langenbecks Arch Surg 2008;393:911-7.
2. Yeo CJ, Cameron JL, Lillemoe KD, Sitzmann JV, Hruban RH, Goodman SN, et al. Pancreaticoduodenectomy for cancer of the head of the pancreas: 201 patients. Ann Surg 1995;221:721-31.
3. Henne-Bruns D, Vogel I, Lüttges J, Klöppel G, Kremer B. Surgery for ductal adenocarcinoma of the pancreatic head: staging, complications, and survival after regional versus extended lymphadenectomy. World J Surg 2000; 24:595-601.
4. Ueda M, Endo I, Nakashima M, Minami Y, Takeda K, Matsuo K, et al. Prognostic factors after resection of pancreatic cancer. World J Surg 2009;33:104-10.
5. Kleeff J, Michalski C, Friess H, Büchler MW. Pancreatic cancer: from bench to 5-year survival. Pancreas 2006;33:111-8. (Pubitemid 44174558)
6. Korc M. Pancreatic cancer-associated stroma production. Am J Surg 2007;194(4 Suppl):S84-6.
7. Farrow B, Albo D, Berger DH. The role of the tumor microenvironment in the progression of pancreatic cancer. J Surg Res 2008;149:319-28.
8. Mantovani A, Allavena P, Sica A, Balkwill F. Cancer-related inflammation. Nature 2008;454:436-44.
9. Arias JI, Aller MA, Sánchez-Patan F, Arias J. Inflammation and cancer: is trophism the link? Surg Oncol 2006;15:235-42.
10. Gulubova M, Vlaykova T. Prognostic significance of mast cell number and microvascular density for the survival of patients with primary colorectal cancer. J Gastroenterol Hepatol 2009;24:1265-75.
11. Nonomura N, Takayama H, Nishimura K, Oka D, Nakai Y, Shiba M, et al. Decreased number of mast cells infiltrating into needle biopsy specimens leads to a better prognosis of prostate cancer. Br J Cancer 2007;97:952-6. (Pubitemid 47519307)
12. Takanami I, Takeuchi K, Naruke M. Mast cell density is associated with angiogenesis and poor prognosis in pulmonary adenocarcinoma. Cancer 2000;88:2686-92. (Pubitemid 30417928)
13. Esposito I, Menicagli M, Funel N, Bergmann F, Boggi U, Mosca F, et al. Inflammatory cells contribute to the generation of an angiogenic phenotype in pancreatic ductal adenocarcinoma. J Clin Pathol 2004;57:630-6. (Pubitemid 38725766)
14. Theoharides TC. Mast cells and pancreatic cancer. N Engl J Med 2008;358:1860-1. (Pubitemid 351581204)
15. Liver including intrahepatic bile ducts. In: Greene F, Page D, Fleming I, eds. American Joint Committee on cancer staging manual. 6th ed. New York: Springer; 2002:131-44.
16. Hsu CY, Ho DM, Yang CF, Chiang H. Interobserver reproducibility of MIB-1 labeling index in astrocytic tumors using different counting methods. Mod Pathol 2003;16:951-7. (Pubitemid 37152026)
17. Ribatti D, Crivellato E. The controversial role of mast cells in tumor growth. Int Rev Cell Mol Biol 2009;275:89-131.
18. Krishnaswamy G, Ajitawi O, Chi DS. The human mast cell: an overview. Methods Mol Biol 2006;315:13-34.
19. Bryne M, Boysen M, Alfsen CG, Abeler VM, Sudbø J, Nesland JM, et al. The invasive front of carcinomas. The most important area for tumour prognosis? Anticancer Res 1998;18:4757-64.
20. Ding T, Xu J, Wang F, Shi M, Zhang Y, Li SP, Zheng L. High tumor-infiltrating macrophage density predicts poor prognosis in patients with primary hepatocellular carcinoma after resection. Hum Pathol 2009;40:381-9.
21. Ibaraki T,Muramatsu M, Takai S, Jin D,Maruyama H, Orino T, et al. The relationship of tryptase- and chymase-positive mast cells to angiogenesis in stage I non-small cell lung cancer. Eur J Cardiothorac Surg 2005;28:617-21. (Pubitemid 41345254)
22. Conti P, Castellani ML, Kempuraj D, Salini V, Vecchiet J, Tetè S, et al. Role of mast cells in tumor growth. Ann Clin Lab Sci 2007;37:315-22. (Pubitemid 350105931)
23. Norrby K. Mast cells and angiogenesis. APMIS 2002;110:355-71.
24. Wasiuk A, de Vries VC, Hartmann K, Roers A, Noelle RJ. Mast cells as regulators of adaptive immunity to tumours. Clin Exp Immunol 2009;155:140-6.
25. Vonlaufen A, Joshi S, Qu C, Phillips PA, Xu Z, Parker NR, et al. Pancreatic stellate cells: partners in crime with pancreatic cancer cells. Cancer Res 2008;68:2085-93. (Pubitemid 351521780)
26. Soucek L, Lawlor ER, Soto D, Shchors K, Swigart LB, Evan GI. Mast cells are required for angiogenesis and macroscopic expansion of Myc-induced pancreatic islet tumors. Nat Med 2007;13:1211-8. (Pubitemid 47530639)
27. Kuwahara K, Sasaki T, Kuwada Y, Murakami M, Yamasaki S, Chayama K. Expressions of angiogenic factors in pancreatic ductal carcinoma: a correlative study with clinicopathologic parameters and patient survival. Pancreas 2003;26:344-9. (Pubitemid 36529959)
28. Takagi K, Takada T, Amano H. A high peripheral microvessel density count correlates with a poor prognosis in pancreatic cancer. J Gastroenterol 2005;40:402-8.
29. Iamaroon A, Pongsiriwet S, Jittidecharaks S, Pattanaporn K, Prapayasatok S, Wanachantararak S. Increase of mast cells and tumor angiogenesis in oral squamous cell carcinoma. J Oral Pathol Med 2003;32:195-9. (Pubitemid 36604013)
30. Ribatti D, Vacca A, Nico B, Crivellato E, Roncali L, Dammacco F. The role of mast cells in tumour angiogenesis. Br J Haematol 2001;115:514-21. (Pubitemid 34015640)
31. Maltby S, Khazaie K, McNagny KM. Mast cells in tumor growth: angiogenesis, tissue remodelling and immune-modulation. Biochim Biophys Acta 2009;1796:19-26.
32. Esposito I, Friess H, Kappeler A, Shrikhande S, Kleeff J, Ramesh H, et al. Mast cell distribution and activation in chronic pancreatitis. Hum Pathol 2001;32:1174-83. (Pubitemid 33104427)
33. Tilki D, Kilic N, Sevinc S, Zywietz F, Stief CG, Ergun S. Zonespecific remodeling of tumor blood vessels affects tumor growth. Cancer 2007;110:2347-62. (Pubitemid 350100758)
34. Hattori Y, Gabata T, Matsui O, Mochizuki K, Kitagawa H, Kayahara M, et al. Enhancement patterns of pancreatic adenocarcinoma on conventional dynamic multi-detector row CT: correlation with angiogenesis and fibrosis. World J Gastroenterol 2009;15:3114-21.
35. Parkash V, Bifulco C, Feinn R, Concato J, Jain D. To count and how to count, that is the question: interobserver and intraobserver variability among pathologists in lymph node counting. Am J Clin Pathol 2010;134:42-9.
36. Baker RW, O'Sullivan JP, Hanley J, Coleman DV. The characteristics of false negative cervical smears-implications for the UK cervical cancer screening programme. J Clin Pathol 1999;52:358-62.
37. Zhu XD, Zhang JB, Zhuang PY, Zhu HG, Zhang W, Xiong YQ, et al. High expression of macrophage colonystimulating factor in peritumoral liver tissue is associated with poor survival after curative resection of hepatocellular carcinoma. J Clin Oncol 2008;26:2707-16.
38. Ranieri G, Ammendola M, Patruno R, Celano G, Zito FA, Montemurro S, et al. Tryptase-positive mast cells correlate with angiogenesis in early breast cancer patients. Int J Oncol 2009;35:115-20.